Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
暂无分享,去创建一个
G. Van den Berghe | P. Ferdinande | F. de Zegher | D. Vlasselaers | M. Schetz | C. Verwaest | P. Lauwers
[1] F. Zegher,et al. Dopamine and the sick euthyroid syndrome in critical illness , 1994, Clinical endocrinology.
[2] T. van der Poll,et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. , 1994, The Journal of clinical endocrinology and metabolism.
[3] M. Kawamata,et al. Suppression of the thyrotropin response to thyrotropin‐releasing hormone and its association with severity of critical illness , 1994, Critical care medicine.
[4] G. Van den Berghe,et al. Growth hormone secretion in critical illness: effect of dopamine. , 1994, The Journal of clinical endocrinology and metabolism.
[5] G. Verleden,et al. Growth hormone as a rescue treatment after heart-lung or double-lung transplantation , 1994 .
[6] E. Krenning,et al. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism , 1993, Clinical endocrinology.
[7] G. Reisz,et al. Effects of dopamine on T‐lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients , 1992, Critical care medicine.
[8] T. van der Poll,et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. , 1990, The Journal of clinical endocrinology and metabolism.
[9] H. Westh,et al. Pituitary-thyroid axis in critical illness. , 1987, The Journal of clinical endocrinology and metabolism.
[10] S. Matsubayashi,et al. Paradoxical responses of plasma cortisol, adrenocorticotropic hormone and growth hormone to thyrotropin-releasing hormone and luteinizing-hormone-releasing hormone in anorexia nervosa patients. , 1986, Psychotherapy and psychosomatics.
[11] K. Swedberg,et al. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. , 1985, The American journal of medicine.
[12] R. I. Gregerman,et al. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. , 1985, The New England journal of medicine.
[13] V. D’orio,et al. The use of low doses of dopamine in intensive care medicine. , 1984, Archives internationales de physiologie et de biochimie.
[14] W. Waldhäusl,et al. Impaired secretion of TSH in critically ill patients with 'low T4-syndrome'. , 1982, Acta endocrinologica.
[15] V. Bacci,et al. The relationship between serum triiodothyronine and thyrotropin during systemic illness. , 1982, The Journal of clinical endocrinology and metabolism.
[16] K. Burman,et al. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". , 1982, Endocrine reviews.
[17] I. Jackson. Thyrotropin-releasing hormone. , 1982, The New England journal of medicine.
[18] H. Krüskemper,et al. Secondary hypothyroidism in severe non thyroidal illness? , 1981, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[19] R. Utiger. Decreased extrathyroidal triiodothyronine production in nonthyroidal illness: benefit or harm? , 1980, The American journal of medicine.
[20] D. Cocchi,et al. INTERACTION BETWEEN THE THYROTROPHIN‐RELEASING HORMONE‐INDUCED GROWTH HORMONE RISE AND DOPAMINERGIC DRUGS: STUDIES IN PATHOLOGIC CONDITIONS OF THE ANIMAL AND MAN , 1979, Clinical endocrinology.
[21] M. Sole,et al. Plasma dopamine responses to standing and exercise in man. , 1979, Life sciences.
[22] R. Sawhney,et al. Serum levels of thyrotropin, thyroid hormones and their response to thyrotropin releasing hormone in infective febrile illnesses. , 1977, The Journal of clinical endocrinology and metabolism.
[23] K. Chihara,et al. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression. , 1975, The Journal of clinical endocrinology and metabolism.
[24] L. I. Goldberg,et al. Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.
[25] P. Snyder,et al. Response to thyrotropin releasing hormone (TRH) in normal man. , 1972, The Journal of clinical endocrinology and metabolism.